Ecnoglutide Reduces HbA1c and Body Weight in Type 2 Diabetes: Meta-Analysis
New diabetes drug cuts sugar and weight in adults with Type 2 Diabetes
A meta-analysis of 1643 adults with type 2 diabetes found that ecnoglutide significantly reduced HbA1c (MD -0.44, 95% CI -0.55 to -0.33) and…
A large review shows ecnoglutide lowers blood sugar and body weight in adults with Type 2 Diabetes. It also has an acceptable safety profile…
A 1-month nudge-based dietary intervention increased daily step counts by 1105 steps at 3 months in adults with type 2 diabetes.
Small diet changes might boost steps for a short time in diabetes care
This cluster-randomised controlled trial enrolled 204 adults aged 18-59 years with type 2 diabetes across 12 primary healthcare centres in B…
A simple diet plan helped people with diabetes walk more for three months but the extra steps did not stick in the long run
Oral Sodium Butyrate Reduces Weight in Overweight Adults Without Diabetes
Oral sodium butyrate helps overweight adults without diabetes lose weight
This 12-week proof-of-concept RCT in 46 overweight adults (23 with type 2 diabetes) found that oral sodium butyrate 1875 mg/day led to great…
A new trial shows oral sodium butyrate helps adults without diabetes lose more weight than a placebo over three months.
Meta-analysis finds GLP-1RA plus SGLT2i reduces UACR in type 2 diabetes with kidney disease
Combining two diabetes drugs protects kidneys better than using just one alone
This systematic review and meta-analysis of 1974 adults with type 2 diabetes and diabetic kidney disease found that combination therapy with…
Combining two common diabetes drugs offers better kidney protection than taking just one alone for people with type 2 diabetes
Mobile app plus group sessions showed feasibility in Malaysian women with gestational diabetes
A new app plus support for diabetes care in Malaysia showed no benefit yet.
This feasibility randomized controlled trial enrolled 60 women with gestational diabetes mellitus in Malaysia. The intervention included mob…
A trial in Malaysia found that a mobile app and group sessions did not improve health outcomes for women with gestational diabetes compared …
Essential phospholipids reduced hepatic steatosis and improved HbA1c in patients with MASLD and type 2 diabetes over 6 months.
Essential Phospholipids Reduce Liver Fat In Six Months
This randomised, placebo-controlled phase 4 trial enrolled 193 patients with metabolic dysfunction-associated steatotic liver disease and ty…
Essential phospholipids may lower liver fat and improve energy levels for people with fatty liver disease and diabetes within just six month…
Systematic review and meta-analysis of hypoglycaemia risk prediction models in type 2 diabetes
Diabetes risk models predict hypoglycemia with moderate accuracy
This systematic review and meta-analysis of 25 studies (45 models) assessed hypoglycaemia risk prediction models in type 2 diabetes. The poo…
Models that predict dangerous blood sugar drops in type 2 diabetes are only moderately accurate, and most studies have serious flaws.
Review of NHANES data links metformin use to lower mortality and inflammatory markers in type 2 diabetes
Metformin use linked to lower death risk and better inflammation markers in U.S. adults with diabetes
This review of NHANES 2013-2018 data (2,116 adults) found that metformin use was associated with lower all-cause and cardiovascular mortalit…
New analysis of U.S. adults with diabetes suggests metformin use connects to lower death risk and improved inflammation markers, though more…
Narrative review discusses pharmacological and lifestyle interventions for type 2 diabetes and psychological health
New hope for diabetes patients struggling with anxiety and depression
This narrative review examines the relationship between type 2 diabetes and conditions such as anxiety, depression, and cognitive impairment…
Diabetes drugs that control blood sugar might also help improve mood and reduce anxiety for patients living with the condition.
Narrative review examines multimorbidity impact on sepsis morbidity and mortality outcomes
Sepsis Risk Skyrockets When You Have Multiple Chronic Conditions
This narrative review synthesizes evidence regarding sepsis in patients with multimorbidity including type 2 diabetes and heart failure. Aut…
Common chronic diseases like diabetes and heart failure create hidden traps that make sepsis much harder to fight and treat.
Guideline narrative review discusses diabetes risks from immunosuppressive therapy in kidney transplant recipients.
Guidelines address diabetes risks in kidney transplant patients
This publication is a narrative review guideline addressing Post-transplant diabetes mellitus and Type 2 Diabetes. The scope covers kidney t…
New guidance outlines considerations for kidney transplant patients dealing with diabetes and medication risks associated with therapy.
Evolocumab reduces cardiovascular events in diabetes without known atherosclerosis
Evolocumab cuts heart events in high-risk diabetes patients
This prespecified subgroup analysis of a phase 3 RCT evaluated evolocumab added to statin therapy in 3655 high-risk patients with type 2 dia…
Adding evolocumab to statins reduced heart attacks and strokes by about 30% in high-risk diabetes patients without known heart disease.